InformationTD-139 TD-139 (GB0-139) is a potent and selective inhibitor of galectin-3 with Kd of 0.036 µM over galectin-1 and galectin-7 with Kd of 2.2 µM and 32 µM, respectively. TD-139 is used potentially for the treatment of idiopathic pulmonary fibrosis (IPF).Targetsgalectin-3 (Cell-free assay); galectin-1 (Cell-free assay); galectin-7 (Cell-free assay) 0.036 μM(Kd); 2.2 μM(Kd); 32 μM(Kd)
Galectin Inhibitors
Specifications & Purity: Moligand™, ≥99%
Grade: Moligand™
Molecular Formula: C28H30F2N6O8S
Molecular Weight: 648.64
PubChem CID: 73774610
Isomeric SMILES: C1=CC(=CC(=C1)F)C2=CN(N=N2)[C@H]3[C@H]([C@H](O[C@H]([C@@H]3O)S[C@H]4[C@@H]([C@H]([C@H]([C@H](O4)CO)O)N5C=C(N=N5)C6=CC(=CC=C6)F)O)CO)O
- UPC:
- 12141734
- Condition:
- New
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- T412406-1mg
- CAS:
- 1450824-22-2
- Product Size:
- 1mg
akash.verma@cenmed.com
(732) 447-1115





